Skip to main content
OpenTrials
Completed

NCT Number: NCT04339803

Dose-Finding of Lower Limb Mirror Therapy After Stroke.

This study will investigate the maximum dose per day of using mirror therapy for ankle exercise after stroke. The design is a 3+3 rule based, dose- finding study. Each cohort will consist of three participants. The first cohort will be assigned to do a dose of 15 minutes each day for two weeks. The second and subsequent cohorts will exercise at target dose set accordance to the nine preset rules and the modified Fibonacci sequence (mFBS).The study will continue until the stopping rule is triggered. The last dose tested will be identified as the maximum tolerable dose per day.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Sarah Bajuaifer

Norwich, NR4 7TJ, United Kingdom

About this study

Procedure:a 3+3 rule-based, dose-escalation design (Colucci et al,2017). recruitment process: the study will begin with a cohort of three participants (n=3). Each of the subsequent cohorts will also be of three participants. The start dose will be set at 15 minutes (cohort one). Participants will do ankle dorsiflexion exercise at the set dose with the mirror for two weeks. The second and subsequent cohorts will exercise at dose set in accordance to the nine preset rules and the modified Fibonacci sequence (mFBS) .

Sample size: The target sample size is not usually predefined for a dose-finding study. The final sample size will be determined by the response of consecutive cohorts to the set dose. Usually, in pharmaceutical dose-finding studies, the sample size lies between 12 and 40.

Data analysis : The data for each cohort will be analysed using descriptive statistics. No significance testing is involved.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants have had a stroke for six weeks or more before recruitment to this study, and are discharged from NHS statutory stroke rehabilitation.
  • Participants will be at least 18 years of age
  • Able to produce some voluntary contraction of paretic ankle ( motricity index between 9 and 19).
  • Ability to understand and follow simple verbal instructions (one-stage commands), i.e. sufficient communication, orientation, and memory to participate in mirror therapy ankle exercise.
  • Participants will have had no lower limb injury in the last six months and were able to walk independently indoors before the index stroke.

Exclusion criteria

  • Foot or ankle contracture that prevents 50% of the passive range of motion.
  • Any condition that can be exaggerated by performing the therapy.

Treatment and study plan

rehabilitation intervention

Other

we use lower limb mirror therapy after stroke for two weeks

Primary outcomes

  1. Changes in the Motricity Index

    Time frame: Baseline, 2 weeks.

Secondary outcomes

  1. Changes in the Symmetry

    Time frame: Baseline, 2 weeks

    in Tibialis anterior muscle activation between the more and less paretic leg

  2. Changes in the Neural excitability

    Time frame: Baseline, 2 weeks

    at the spinal level using peripheral nerve stimulation-H reflex

  3. changes in the Transcranial magnetic stimulation (TMS)

    Time frame: Baseline, 2 weeks

    Corticospinal tract excitability

Sponsors and collaborators

Lead sponsor

University of East Anglia

Other

Registry information

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Apr 9, 2020
Registry last updated
Nov 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.